| Clin Diagn Lab Immunol. 1995 May; 2(3): 322–324. | PMCID: PMC170153 |
Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. K Matsuda, H Tsutsumi, Y Okamoto, and C Chiba Department of Pediatrics, Sapporo Medical University School of Medicine, Japan. Abstract Cytokine (interleukin 6 [IL-6] and tumor necrosis factor alpha [TNF-alpha]) activity in nasopharyngeal secretions of 21 infants and children (19 days to 16 months old) infected with primary respiratory syncytial virus was determined by an enzyme-linked immunosorbent assay. IL-6 and TNF-alpha were detectable in 100% (21 of 21) and 67% (14 of 21) of cases during the course of infection, respectively. Generally, TNF-alpha activity was high in the acute phase and declined thereafter, sometimes to undetectable levels. IL-6 activity was also highest in the acute phase and declined thereafter in infants younger than 5 months, while in patients older than 5 months, it-increased during the course of the disease to peak in the early convalescent phase. These observations suggest that inflammatory cytokines are produced in vivo in infants and children in response to primary respiratory syncytial virus infection and may be involved in disease pathogenesis. However, the mechanism of induction of cytokines may be different for infants and children in different age groups. Full Text The Full Text of this article is available as a PDF (164K). These references are in PubMed. This may not be the complete list of references from this article. - Arnold, R; Werner, F; Humbert, B; Werchau, H; König, W. Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes. Immunology. 1994 Jun;82(2):184–191. [PubMed]
- Beagley, KW; Eldridge, JH; Lee, F; Kiyono, H; Everson, MP; Koopman, WJ; Hirano, T; Kishimoto, T; McGhee, JR. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med. 1989 Jun 1;169(6):2133–2148. [PubMed]
- Becker, S; Quay, J; Soukup, J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol. 1991 Dec 15;147(12):4307–4312. [PubMed]
- Hayes, PJ; Scott, R; Wheeler, J. In vivo production of tumour necrosis factor-alpha and interleukin-6 in BALB/c mice inoculated intranasally with a high dose of respiratory syncytial virus. J Med Virol. 1994 Apr;42(4):323–329. [PubMed]
- Hennet, T; Ziltener, HJ; Frei, K; Peterhans, E. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol. 1992 Aug 1;149(3):932–939. [PubMed]
- Kimman, TG; Westenbrink, F. Immunity to human and bovine respiratory syncytial virus. Arch Virol. 1990;112(1-2):1–25. [PubMed]
- Midulla, F; Villani, A; Panuska, JR; Dab, I; Kolls, JK; Merolla, R; Ronchetti, R. Respiratory syncytial virus lung infection in infants: immunoregulatory role of infected alveolar macrophages. J Infect Dis. 1993 Dec;168(6):1515–1519. [PubMed]
- Morahan, PS; Connor, JR; Leary, KR. Viruses and the versatile macrophage. Br Med Bull. 1985 Jan;41(1):15–21. [PubMed]
- Mufson, MA; Belshe, RB; Orvell, C; Norrby, E. Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986. J Infect Dis. 1988 Jan;157(1):143–148. [PubMed]
- Murphy, BR; Graham, BS; Prince, GA; Walsh, EE; Chanock, RM; Karzon, DT; Wright, PF. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol. 1986 Jun;23(6):1009–1014. [PubMed]
- Nagai, K; Tsutsumi, H; Yamazaki, H; Pattamadilok, S; Chiba, S. Three antigenic variant groups in human respiratory syncytial virus subgroup B isolated in Japan. Arch Virol. 1993;128(1-2):55–63. [PubMed]
- Nathan, C; Sporn, M. Cytokines in context. J Cell Biol. 1991 Jun;113(5):981–986. [PubMed]
- Neilson, KA; Yunis, EJ. Demonstration of respiratory syncytial virus in an autopsy series. Pediatr Pathol. 1990;10(4):491–502. [PubMed]
- Panuska, JR; Cirino, NM; Midulla, F; Despot, JE; McFadden, ER, Jr; Huang, YT. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J Clin Invest. 1990 Jul;86(1):113–119. [PubMed]
- Panuska, JR; Hertz, MI; Taraf, H; Villani, A; Cirino, NM. Respiratory syncytial virus infection of alveolar macrophages in adult transplant patients. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):934–939. [PubMed]
- Panuska, JR; Midulla, F; Cirino, NM; Villani, A; Gilbert, IA; McFadden, ER, Jr; Huang, YT. Virus-induced alterations in macrophage production of tumor necrosis factor and prostaglandin E2. Am J Physiol. 1990 Dec;259(6 Pt 1):L396–L402. [PubMed]
- Parrott, RH; Kim, HW; Arrobio, JO; Hodes, DS; Murphy, BR; Brandt, CD; Camargo, E; Chanock, RM. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol. 1973 Oct;98(4):289–300. [PubMed]
- Rodgers, BC; Mims, CA. Influenza virus replication in human alveolar macrophages. J Med Virol. 1982;9(3):177–184. [PubMed]
- Tsutsumi, H; Nagai, K; Suga, K; Chiba, Y; Chiba, S; Tsugawa, S; Ogra, PL. Antigenic variation of human RSV strains isolated in Japan. J Med Virol. 1989 Feb;27(2):124–130. [PubMed]
- Wong, GH; Goeddel, DV. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature. 323(6091):819–822. [PubMed]
- Yamazaki, H; Tsutsumi, H; Matsuda, K; Nagai, K; Ogra, PL; Chiba, S. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection. J Gen Virol. 1994 Aug;75(Pt 8):2115–2119. [PubMed]
- Yamazaki, H; Tsutsumi, H; Matsuda, K; Nagai, K; Ogra, PL; Chiba, S. Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection. Clin Diagn Lab Immunol. 1994 Jul;1(4):469–472. [PubMed]
|
This article has been 
